|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:Humalog
gptkb:Rapid-acting_insulin
|
|
gptkbp:activities
|
mimics endogenous insulin
|
|
gptkbp:appointed_by
|
subcutaneous injection
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:availability
|
prescription only
|
|
gptkbp:brand
|
gptkb:Humalog
|
|
gptkbp:can_be_used_with
|
gptkb:metformin
sulfonylureas
glargine
|
|
gptkbp:clinical_trial
|
Phase III
blood glucose control
|
|
gptkbp:contraindication
|
hypoglycemia
|
|
gptkbp:developed_by
|
gptkb:Eli_Lilly_and_Company
|
|
gptkbp:duration
|
3 to 6 hours
|
|
gptkbp:education
|
monitoring blood sugar levels
recognizing hypoglycemia
dietary considerations
how to inject insulin
insulin storage guidelines
|
|
gptkbp:financial_performance
|
28 days at room temperature
|
|
gptkbp:formulation
|
gptkb:software_framework
injectable
|
|
gptkbp:frequency
|
before meals
|
|
gptkbp:highest_point
|
30 to 90 minutes
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
insulin lispro
|
|
gptkbp:indication
|
mealtime insulin therapy
|
|
gptkbp:ingredients
|
C257 H383 N65 O77 S
|
|
gptkbp:interacts_with
|
gptkb:beer
gptkb:ACE_inhibitors
beta-blockers
thiazide diuretics
|
|
gptkbp:invention
|
gptkb:2016
patented
|
|
gptkbp:investment
|
gptkb:lipodystrophy
allergic reactions
diabetic ketoacidosis
|
|
gptkbp:is_available_on
|
gptkb:printer
gptkb:tablet
vial
|
|
gptkbp:is_monitored_by
|
blood glucose levels
|
|
gptkbp:is_used_for
|
gptkb:Company
|
|
gptkbp:manager
|
subcutaneous
|
|
gptkbp:marketed_as
|
gptkb:1996
|
|
gptkbp:pharmacokinetics
|
insulin receptor agonist
rapid absorption
|
|
gptkbp:population
|
gptkb:Person
adults
|
|
gptkbp:premiered_on
|
15 minutes
|
|
gptkbp:previous_name
|
gptkb:insulin_lispro
|
|
gptkbp:price
|
varies by region
|
|
gptkbp:provides_information_on
|
ADA Standards of Medical Care
AACE Diabetes Management Guidelines
Endocrine Society Guidelines
|
|
gptkbp:safety_features
|
Category B
|
|
gptkbp:side_effect
|
weight gain
injection site reactions
hypoglycemia
|
|
gptkbp:storage
|
refrigerated
|
|
gptkbp:traded_on
|
gptkb:Humalog_Mix
|
|
gptkbp:type
|
rapid-acting insulin
|
|
gptkbp:weight
|
5808.4 g/mol
|